Analysts expect Ensysce Biosciences, Inc. to report revenue of 1.15 M for Q3 26, against a range of 1.10 M to 1.21 M. The most recent reported quarter, Q2 26, came in at 1.20 M, a 5.3% beat against the 1.14 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 3.41 M | 1.30 M | 1.31 M | 1.37 M | 493,100.00 | 1.90 M | 1.00 M | 1.20 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 3.95 M | 265,810.79 | 0.00 | 659,099.94 | 723,892.83 | 548,257.99 | 1.91 M | 1.19 M | 1.21 M | 1.20 M | 1.70 M | 1.48 M | 996,357.64 | 881,769.85 | 243,812.88 | 422,906.17 | ||||||||||
| Low Estimate | 3.32 M | 236,983.11 | 0.00 | 585,929.56 | 634,548.17 | 490,827.73 | 1.66 M | 1.09 M | 1.10 M | 1.07 M | 1.45 M | 1.39 M | 874,687.32 | 807,603.01 | 221,424.28 | 357,521.19 | ||||||||||
| Consensus Estimate | 3.63 M | 251,396.95 | 0.00 | 622,514.75 | 679,220.50 | 519,542.86 | 1.78 M | 1.14 M | 1.15 M | 1.13 M | 1.57 M | 1.44 M | 935,522.48 | 844,686.43 | 232,618.58 | 390,213.68 |
Analysts expect Ensysce Biosciences, Inc. to report earnings per share of -0.12 for Q3 26, against a range of -0.13 to -0.11. The most recent reported quarter, Q2 26, came in at -0.20, a 5.3% miss against the -0.19 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.05 | -2.90 | -1.39 | -0.79 | -1.29 | -0.75 | -0.52 | -0.20 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.10 | -2.43 | -2.71 | -0.89 | -0.80 | -1.12 | -0.62 | -0.18 | -0.11 | -0.09 | -0.01 | -0.01 | -0.23 | -0.26 | 0.31 | 0.30 | ||||||||||
| Low Estimate | 0.92 | -2.81 | -3.07 | -1.07 | -0.92 | -1.30 | -0.74 | -0.20 | -0.13 | -0.09 | -0.01 | -0.01 | -0.25 | -0.28 | 0.27 | 0.26 | ||||||||||
| Consensus Estimate | 1.01 | -2.62 | -2.89 | -0.98 | -0.86 | -1.21 | -0.68 | -0.19 | -0.12 | -0.09 | -0.01 | -0.01 | -0.24 | -0.27 | 0.29 | 0.28 |
Pull Wall Street consensus for Ensysce Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ENSC&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ENSC", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ENSC&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();